Managed Healthcare Executive November 20, 2024
Rosanna Sutherby, Pharm.D.

Binghampton University in New York state will join Mayo Clinic and at least 15 other investigators in developing an implant aimed to treat inflammatory diseases. The project, called Engage Assess SecretE (EASE): A Platform for Treating Chronic Inflammation, is meant to act as a “living pharmacy” triggering cells to produce antibodies that could target inflammatory conditions.

The EASE project, led by Alexander Revzin, Ph.D., biochemical engineer at Mayo Clinic, is funded by a $42.8 million grant from the Advanced Research Projects Agency for Health (ARPA-H), an agency nestled under the Department of Health and Human Services and the National Institutes of Health. ARPA-H funds and supports biomedical and health research with the potential for developing high-impact and transformative treatments.

Mayo...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Health System / Hospital, Provider
Q&A: Researcher discusses agentic AI, expected to be the next trend in digital medicine
As rural America faces ‘a dire health crisis,’ urgent action is needed, ACP says
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
Beacon Health System to acquire 36 Ascension outpatient clinics, ASCs
Why this system is launching 7 new behavioral health programs

Share This Article